| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ... Nature genetics 45 (6), 670-675, 2013 | 431 | 2013 |
| Genome-wide association analysis in primary sclerosing cholangitis TH Karlsen, A Franke, E Melum, A Kaser, JR Hov, T Balschun, BA Lie, ... Gastroenterology 138 (3), 1102-1111, 2010 | 404 | 2010 |
| Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci E Melum, A Franke, C Schramm, TJ Weismüller, DN Gotthardt, FA Offner, ... Nature genetics 43 (1), 17-19, 2011 | 286 | 2011 |
| Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci T Folseraas, E Melum, P Rausch, BD Juran, E Ellinghaus, A Shiryaev, ... Journal of hepatology 57 (2), 366-375, 2012 | 242 | 2012 |
| Autoantibodies in primary sclerosing cholangitis JR Hov, KM Boberg, TH Karlsen World journal of gastroenterology: WJG 14 (24), 3781, 2008 | 225 | 2008 |
| Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 D Ellinghaus, T Folseraas, K Holm, E Ellinghaus, E Melum, T Balschun, ... Hepatology 58 (3), 1074-1083, 2013 | 200 | 2013 |
| Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis JR Hov, V Keitel, JK Laerdahl, L Spomer, E Ellinghaus, A ElSharawy, ... PloS one 5 (8), e12403, 2010 | 138 | 2010 |
| Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis IM Andersen, G Tengesdal, BA Lie, KM Boberg, TH Karlsen, JR Hov Clinical Gastroenterology and Hepatology 12 (6), 1019-1028, 2014 | 88 | 2014 |
| FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis A Wannhoff, JR Hov, T Folseraas, C Rupp, K Friedrich, JA Anmarkrud, ... Journal of hepatology 59 (6), 1278-1284, 2013 | 85 | 2013 |
| Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis JR Hov, V Kosmoliaptsis, JA Traherne, M Olsson, KM Boberg, A Bergquist, ... Hepatology 53 (6), 1967-1976, 2011 | 66 | 2011 |
| Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease S Næss, E Björnsson, JA Anmarkrud, SA Mamari, BD Juran, KN Lazaridis, ... Liver international 34 (10), 1488-1495, 2014 | 58 | 2014 |
| PNPLA3 in end‐stage liver disease: Alcohol consumption, hepatocellular carcinoma development, and transplantation‐free survival K Friedrich, A Wannhoff, S Kattner, M Brune, JR Hov, KH Weiss, C Antoni, ... Journal of gastroenterology and hepatology 29 (7), 1477-1484, 2014 | 58 | 2014 |
| Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C JR Hov, A Lleo, C Selmi, B Woldseth, L Fabris, M Strazzabosco, ... Journal of Hepatology 52 (5), 712-717, 2010 | 57 | 2010 |
| A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis K Friedrich, C Rupp, JR Hov, N Steinebrunner, KH Weiss, A Stiehl, ... PLoS One 8 (3), e58734, 2013 | 40 | 2013 |
| TGR5 sequence variation in primary sclerosing cholangitis JR Hov, V Keitel, E Schrumpf, D Häussinger, TH Karlsen Digestive Diseases 29 (1), 78-84, 2011 | 30 | 2011 |
| Genetics in primary sclerosing cholangitis S Næss, A Shiryaev, JR Hov, A Franke, TH Karlsen Clinics and research in hepatology and gastroenterology 36 (4), 325-333, 2012 | 26 | 2012 |
| Genetics of cholestatic liver disease in 2010 TH Karlsen, JR Hov Current opinion in gastroenterology 26 (3), 251-258, 2010 | 24 | 2010 |
| Agreement of a child's respiratory symptom diary with parental reports and peak expiratory flow JR Hov, J Clench-Aas, A Bartonova, K Stavem The International journal of tuberculosis and lung disease 13 (3), 400-406, 2009 | 7 | 2009 |
